Mark Kendall of the University of Queensland in Australia will design and test nanopatches, small patches consisting of microscopic silicon projections coated with a malaria vaccine in dry form, to target immunologically-sensitive cells within the skin's outer layers - that are missed by the needle and syringe - to induce unique and protective immune response against the disease.
Grant ID
OPP51990
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False